Owing to time restrictions, longer term follow-up of participants was not feasible within the current study, although it is hoped that a two year follow-up of the present study’s participants is possible. The significant group difference seen at three months, dropping slightly at six months, but reaching significance again at nine months, could be an indication of sustained change. Another limitation of the study design was that secondary outcome assessors were not blinded to treatment allocation, which could have introduced bias in follow-up data collection of secondary variables.
In Type 1 Diabetes, symptoms are often sudden and can be life-threatening; therefore it is usually diagnosed quite quickly. In Type 2 Diabetes, many people have no symptoms at all, while other signs can go unnoticed, being seen as part of ‘getting older’. Therefore, by the time symptoms are noticed, complications of diabetes may already be present.
“It was fantastic for me to have all this information on the screen so I didn’t need to look it up. It means that I can see the latest results and any patterns that emerge on screen, without having to look them up, and yet I can interact with Ellen and the patient as I have a really good picture and good sound. At first, I was worried that the telehealth clinic would be too impersonal but it isn’t and the patients get quickly familiar with the setup and seeing and talking to me onscreen.”